Barbers Can Partner With Dermatologists to Augment Pseudofolliculitis Barbae Care
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Dec. 11, 2023 -- An educational intervention targeted at barbers substantially increases knowledge regarding the causes, prevention, and treatment of pseudofolliculitis barbae (PFB), according to a research letter published online Dec. 6 in JAMA Dermatology.
Xavier Rice, M.D., from the University of Texas Medical Branch in Galveston, and colleagues evaluated the effectiveness of an educational intervention as a pilot for allyship between barbers and dermatologists to address gaps in PFB care. Forty barbers were surveyed before and after an intervention, which included a comprehensive educational pamphlet on the recognition, cause, prevention, and treatment of PFB, as well as common myths and home remedies.
The researchers found that before the intervention, there was near unanimous participant understanding (97.5 percent) that Black men were the group most affected by PFB and that severe forms of PFB should be evaluated by a physician. Yet, only 30 percent of barbers correctly identified the PFB photograph in the pretest survey compared with 97.5 percent in the posttest survey. In the posttest survey, 92.5 percent of barbers recognized laser hair removal as the most effective treatment for PFB, versus only 5 percent pretest.
"Educating barbers on dermatologic conditions that disproportionately affect Black males and establishing referral services between barbers and dermatologists could serve as plausible interventions," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-12 02:15
Read more
- Season of Birth Linked to Asthma, Allergic Rhinitis
- GSK Receives US FDA Breakthrough Therapy Designation for B7-H3-Targeted Antibody-Drug Conjugate GSK5764227 in Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer
- A Guide on What to Eat During Pregnancy
- 15 Healthy Staples You Should Always Have on Hand
- How to Keep Chickens: Tips and Walkthrough
- Is It Better to Be a Night Owl or Early Bird?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions